On May 17, 2016, researchers of the National Academies of Sciences, Engineering, and Medicine published a 420-page report on Genetically Engineered Crops: Experiences and Prospects.
For over 40 years, researchers have conducted many issues of economics, agronomy (in the context of farming), health, safety (environmental impact) and other effects of genetically engineered crops and food products. Scientists have studied all the potential risks associated with the use of GMOs. The purpose of the study was to provide an independent, objective examination based on all available data.
Since 1970 about 1,000 scientific articles about the influence of GM crops on the human body and the environment have been published. Over 50 scientists and 26 independent experts have carried out an analysis of the available data for 2 years.
The result of the study - there are no signs of harmful effects of GMOs on human health.
There is no correlation between the GM crops and development of cancer, obesity, diabetes, the kidney and digestive system diseases, autism and allergies.
Since the mass distribution of GMOs in the US and Canada, there has been no increase in morbidity. Moreover, experts have found the positive impact of GMOs on human health due to a reduction in poisoning (pesticides, insecticides) and increased levels of vitamins, nutrients in GM products.
Commenting on the results of the report to the USA Today publication, Phil Lempert, the food industry analyst, said about GMOs: "This is an emotional issue, not a scientific problem."
Authors of the report:
- Committee on Genetically Engineered Crops;
- Board on Agriculture and Natural Resources;
- Division of Earth and Life Studies;
- National Academies of Sciences, Engineering, and Medicine.
All medical content on this page is prepared by authors with specialized medical education and reviewed by certified physicians in the relevant field. Medical review by Fahad Mawlood, Medical Editor & Data Scientist.
Last updated: October 18, 2023.
- Statistics: Figures are based on Bookimed’s internal database January 2026, which includes analysis of 12,450 patient requests across accredited clinics in .
- Pricing: Cost information is provided directly by Bookimed’s partner clinics and updated regularly to reflect current 2026 market conditions. Actual expenses may differ depending on case complexity, surgeon expertise, and clinic location.
- Clinical Data: Treatment outcomes and patient satisfaction figures are collected from Bookimed’s verified clinic database and supported by data from peer-reviewed medical sources such as PubMed, The Lancet, JAMA, and NEJM (2023–2026).
All data is provided for general informational purposes and may not represent individual results or experiences.


